Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.05
Bid: 3.30
Ask: 4.80
Change: 0.19 (4.92%)
Spread: 1.50 (45.455%)
Open: 3.86
High: 0.00
Low: 0.00
Prev. Close: 3.86
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proteome Hails "Encouraging" Interim Progress As Loss Improves

Thu, 25th Jul 2019 12:33

(Alliance News) - Life sciences firm Proteome Sciences PLC said Thursday momentum continued to build in the first half of 2019, with losses improving after revenue jumped and costs fell.

For the six months ended June, the pretax loss improved to GBP410,000 from GBP1.4 million the year prior. This was after revenue rose 31% to GBP1.7 million from GBP1.3 million the year before.

Profit performance was helped by a sharp fall in administrative costs to GBP1.2 million from GBP2.0 million the year prior.

"Performance during the first six months of 2019 was very encouraging, building on the momentum developed in the second half of 2018," Chief Executive Jeremy Haigh said.

"Recognised revenues from our services platform were significantly ahead of the equivalent period in 2018 and, most importantly, we issued a record number of quotes for new business in the second quarter, a fundamental lead indicator of future customer engagement," Haigh added.

Services revenue surged 30% to GBP350,000 from GBP270,000 the year prior.

"Administrative costs continue to reduce, and cash reserves are stronger; as a consequence, the company is beginning to demonstrate a much-anticipated level of fiscal stability and growth which should enable some near-term investment that will be vital if we are to remain competitive in such a rapidly developing market," Haigh continued.

"We are confident that our commercial strategy is starting to gain traction after a slow start early in 2018 and, with the promise of a stronger second half which has been characteristic of previous years, we expect to report further progress", Haigh concluded.

Shares in Proteome were 4.7% lower at 3.58 pence in London on Thursday.

More News
30 Nov 2010 13:34

Small caps round-up: Tinci, Nasstar, 600 Group...

Environmental engineering group Tinci Holdings jumped after it announced contracts worth 45.4m Chinese Renminbi (£4.34m) to provide paper desulfurisation technology to two subsidiaries of the Dongguan Jiulong Paper Group. These projects are expected to start shortly and last for about six months. N

Read more
13 Jul 2010 09:30

UK SMALLCAP ROUNDUP: African Minerals Gets $1.5B For Tonkolili

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps AFRICAN MINERALS LTD. (AMI.LN), an iron ore miner focused on Sierra Leone, Tuesday said it agreed a $1.5 billion investment in its Tonkolili project from

Read more
13 Jul 2010 08:03

Proteome Sciences Develops Two Alzheimer's Tests

LONDON (Dow Jones)--Diagnostics company Proteome Sciences PLC (PRM.LN) Tuesday said it developed two tests focused on aspects of Alzheimer's disease. The company, which specializes in identifying proteins that could be hallmarks of disease, said one of the tests measures levels of nine proteins

Read more
18 Jun 2010 07:25

Proteome Sciences: German Court To Hear Sanofi Case End July

LONDON (Dow Jones)--Proteome Sciences PLC (PRM.LN), a life sciences company delivering content for personalised medicine, said Friday it has received notification from the Civil Division of the Higher Regional Court in Frankfurt that the Court now intends to take witness evidence at the end of July

Read more
6 Jul 2009 07:17

Proteome seals Alzheimer's tie-up

Proteome Sciences has signed an exclusive license agreement with Millipore Corp to develop new products aimed at helping advance the study of Alzheimer's disease. The disease identification specialist says Millipore will develop Luminex bead-based multiplex immunoassays to measure Proteome Sciences

Read more
18 Jun 2009 08:08

Proteome extends loan facility

Revenue rose strongly at disease identification specialist Proteome Sciences last year but cash inflows have fallen short of expectations. Revenue in 2008 rose to £0.85m from £0.27m in 2007 while loss before tax narrowed to £4.8m from £5.5m the year before. Cash in hand at the end of 2008 stood at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.